Literature DB >> 20477735

Hospitalisation of Indigenous children in the Northern Territory for lower respiratory illness in the first year of life.

Kerry-Ann F O'Grady1, Paul J Torzillo, Anne B Chang.   

Abstract

OBJECTIVE: To describe the epidemiology of acute lower respiratory infection (ALRI) and bronchiectasis in Northern Territory Indigenous infants hospitalised in the first year of life.
DESIGN: A historical cohort study constructed from the NT Hospital Discharge Dataset and the NT Immunisation Register. PARTICIPANTS AND
SETTING: All NT resident Indigenous infants, born 1 January 1999 to 31 December 2004, admitted to NT public hospitals and followed up to 12 months of age. MAIN OUTCOME MEASURES: Incidence of ALRI and bronchiectasis (ICD-10-AM codes) and radiologically confirmed pneumonia (World Health Organization protocol).
RESULTS: Data on 9295 infants, 8498 child-years of observation and 15 948 hospitalised episodes of care were analysed. ALRI incidence was 426.7 episodes per 1000 child-years (95% CI, 416.2-437.2). Incidence rates were two times higher (relative risk, 2.12; 95% CI, 1.98-2.27) for infants in Central Australia compared with those in the Top End. The median age at first admission for an ALRI was 4.6 months (interquartile range, 2.6-7.3). Bronchiolitis accounted for most of the disease burden, with a rate of 227 per 1000 child-years. The incidence of first diagnosis of bronchiectasis was 1.18 per 1000 child-years (95% CI, 0.60-2.16). One or more key comorbidities were present in 1445 of the 3227 (44.8%) episodes of care for ALRI.
CONCLUSIONS: Rates of ALRI and bronchiectasis in NT Indigenous infants are excessive, with early onset, frequent repeat episodes, and a high prevalence of comorbidities. These high rates of disease demand urgent attention.

Entities:  

Mesh:

Year:  2010        PMID: 20477735

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  30 in total

1.  Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.

Authors:  Anne B Chang; Keith Grimwood; Colin F Robertson; Andrew C Wilson; Peter P van Asperen; Kerry-Ann F O'Grady; Theo P Sloots; Paul J Torzillo; Emily J Bailey; Gabrielle B McCallum; Ian B Masters; Catherine A Byrnes; Mark D Chatfield; Helen M Buntain; Ian M Mackay; Peter S Morris
Journal:  Trials       Date:  2012-08-31       Impact factor: 2.279

2.  Use of health services by remote dwelling Aboriginal infants in tropical northern Australia: a retrospective cohort study.

Authors:  Sarah J Bar-Zeev; Sue G Kruske; Lesley M Barclay; Naor H Bar-Zeev; Jonathan R Carapetis; Sue V Kildea
Journal:  BMC Pediatr       Date:  2012-02-28       Impact factor: 2.125

3.  Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol.

Authors:  Anne B Chang; Keith Grimwood; Andrew V White; Carolyn Maclennan; Theo P Sloots; Alan Sive; Gabrielle B McCallum; Ian M Mackay; Peter S Morris
Journal:  Trials       Date:  2011-04-14       Impact factor: 2.279

Review 4.  Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori children.

Authors:  Anne B Chang; Robyn L Marsh; John W Upham; Lucas R Hoffman; Heidi Smith-Vaughan; Deborah Holt; Maree Toombs; Catherine Byrnes; Stephanie T Yerkovich; Paul J Torzillo; Kerry-Ann F O'Grady; Keith Grimwood
Journal:  Front Pediatr       Date:  2015-02-13       Impact factor: 3.418

5.  The respiratory health of urban indigenous children aged less than 5 years: study protocol for a prospective cohort study.

Authors:  Kerry K Hall; Anne B Chang; Theo P Sloots; Jennie Anderson; Anita Kemp; Jan Hammill; Michael Otim; Kerry-Ann F O'Grady
Journal:  BMC Pediatr       Date:  2015-05-14       Impact factor: 2.125

Review 6.  Improving the Diagnosis, Management, and Outcomes of Children with Pneumonia: Where are the Gaps?

Authors:  Anne B Chang; Mong H Ooi; David Perera; Keith Grimwood
Journal:  Front Pediatr       Date:  2013-10-23       Impact factor: 3.418

7.  Absence of human papillomavirus in nasopharyngeal swabs from infants in a population at high risk of human papillomavirus infection.

Authors:  Heidi C Smith-Vaughan; Allen C Cheng; Sepehr N Tabrizi; Danielle F Wurzel; Jemima Beissbarth; Amanda J Leach; Peter S Morris; Michael J Binks; Paul J Torzillo; Anne B Chang; Robyn L Marsh
Journal:  Pediatr Investig       Date:  2021-06-18

8.  Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.

Authors:  Anne B Chang; Keith Grimwood; Andrew C Wilson; Peter P van Asperen; Catherine A Byrnes; Kerry-Ann F O'Grady; Theo P Sloots; Colin F Robertson; Paul J Torzillo; Gabrielle B McCallum; Ian B Masters; Helen M Buntain; Ian M Mackay; Jacobus Ungerer; Joanne Tuppin; Peter S Morris
Journal:  Trials       Date:  2013-02-20       Impact factor: 2.279

Review 9.  Humidity and respiratory virus transmission in tropical and temperate settings.

Authors:  S Paynter
Journal:  Epidemiol Infect       Date:  2014-10-13       Impact factor: 4.434

10.  A single dose of azithromycin does not improve clinical outcomes of children hospitalised with bronchiolitis: a randomised, placebo-controlled trial.

Authors:  Gabrielle B McCallum; Peter S Morris; Mark D Chatfield; Carolyn Maclennan; Andrew V White; Theo P Sloots; Ian M Mackay; Anne B Chang
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.